---
title: "15-Minute Monday Advantage Mini Webinar: First Edition"
description: "The Finals: How MA Plans should position themselves after the Final Rate and Final Rule for 2026. Watch our min-webinar or read a quick rundown."
image: https://info.nymblscience.com/hubfs/Mini-webinar%20Featured%20Image.jpeg
---

[![Nymbl Science](https://info.nymblscience.com/hs-fs/hubfs/Nymbl_PrimaryLockup-RGB.png?width=3924&height=1586&name=Nymbl_PrimaryLockup-RGB.png "Nymbl Science")](http://www.nymblscience.com)

[Open the Nymbl App](https://my.nymblscience.com/InApp/)

# 15-Minute Monday Advantage Mini Webinar: First Edition

 The Nymbl Team  May 19, 2025

 Copy Link

 

## Mini-webinar Rundown

 

- **Revenue Boost, But With Strings Attached.** CMS finalized an average 5% revenue increase for MA plans in 2026, driven primarily by higher fee-for-service Medicare costs. While this is a financial positive, it comes with heightened regulatory scrutiny and rising expectations around access, quality, and fiduciary responsibility.

- **Inflation Reduction Act Becomes Reality.** Several IRA provisions are now formally codified: $2,000 annual out-of-pocket cap for Part D, Manufacturer discount program, and the N3P monthly cost smoothing program. These changes mean more financial risk for plans, particularly in the catastrophic phase of Part D coverage.
- **Stars & Quality: Be Proactive, Not Reactive.** Breast cancer screening measures will expand to include ages 40-49 by 2027. Plans should begin analyzing this population now. For D-SNPs, integration is no longer optional. Plans must implement integrated IDs and HRAs by 2027 and prepare for enhanced alignment requirements.
- **SSBCI Nutrition Restrictions Are Coming.** CMS will prohibit coverage of “non-healthy” food under SSBCI starting in 2026. Plans should proactively redefine benefits, update FlexCards, and communicate changes to avoid member frustration and Stars penalties.
- **Unaddressed but Critical: AI, Obesity Drugs, and More.** Despite growing use of AI in UM and coding, CMS has not yet issued clear guardrails—plans piloting AI should implement governance policies now. No final decision on GLP-1 or anti-obesity drug coverage, but mounting pressure suggests this could become a major financial and policy issue soon.

## Speakers

 

- [Dr. Ed Likovich](https://www.linkedin.com/in/edwardlikovich/), PHD, CEO of Nymbl.
- [Jessica Muratore](https://www.linkedin.com/in/jessicamuratore/), Strategic healthcare advisor helping health plans and vendors navigate complex government programs. 
- [Andrew Bell](https://www.linkedin.com/in/andrew-bell-9428265a/), Managing Director at Prosphire, a national healthcare consulting firm, overseeing their Medicare Advantage practice.

 

### Book a Meeting

![Voss_Circle Headshot](https://info.nymblscience.com/hs-fs/hubfs/Signatures/Voss_Circle%20Headshot.png?width=250&height=250&name=Voss_Circle%20Headshot.png)Jeff Voss  
SVP of Sales

 

[![Book a meeting button (2)](https://info.nymblscience.com/hs-fs/hubfs/Book%20a%20meeting%20button%20(2).png?width=300&height=39&name=Book%20a%20meeting%20button%20(2).png)](https://calendly.com/jeff-voss-nymblscience/30min)

Nymbl Science

2000 S. Colorado Blvd,  
Tower 2, Suite 320  
Denver, CO 80222

[![LinkedIn](data:image/svg+xml;base64,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) ](https://www.linkedin.com/company/nymbl-science/) [![Email](data:image/svg+xml;base64,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)](mailto:support@nymblscience.com)

[Privacy Policy](https://nymblscience.com/privacy) [Terms of Service](https://nymblscience.com/terms-of-service)

 ©  Nymbl Science, Inc. All Rights Reserved

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "The Nymbl Team",
    "url" : "https://info.nymblscience.com/resources/author/the-nymbl-team"
  },
  "dateModified" : "2025-05-19T21:45:49.677Z",
  "datePublished" : "2025-05-19T20:30:00.000Z",
  "headline" : "15-Minute Monday Advantage Mini Webinar: First Edition",
  "image" : [ "https://info.nymblscience.com/hubfs/Mini-webinar%20Featured%20Image.jpeg" ],
  "mainEntityOfPage" : {
    "@id" : "https://info.nymblscience.com/resources/15-minute-monday-advantage-may-2025",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://info.nymblscience.com/hubfs/Nymbl_PrimaryLockup-RGB.png"
    },
    "name" : "Nymbl Science Inc"
  }
}
```

```json
{
  "@context" : "https://schema.org",
  "@type" : "VideoObject",
  "contentUrl" : "https://5113115.fs1.hubspotusercontent-na2.net/hubfs/5113115/GMT20250512-170012_Recording_640x360%20(1).mp4",
  "dateModified" : "2025-05-19T14:59:49.235Z",
  "duration" : "PT14M26S",
  "height" : 360,
  "name" : "GMT20250512-170012_Recording_640x360 (1)",
  "thumbnailUrl" : "https://5113115.fs1.hubspotusercontent-na1.net/hubfs/5113115/GMT20250512-170012_Recording_640x360%20(1).mp4/medium.jpg?t=1747666789235",
  "uploadDate" : "2025-05-19T14:59:34.484Z",
  "width" : 640
}
```